These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2410697)

  • 1. Myocardial bethanidine kinetics after single-dose intravenous infusion: correlation with plasma kinetics in closed-chest dogs.
    Anderson JL; Anastasiou-Nana M; Dayton VD; Creagar RN; Jensen RL; Wright GJ
    J Cardiovasc Pharmacol; 1985; 7(3):609-12. PubMed ID: 2410697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orally.
    Bacaner MB; Hoey MF; Macres MG
    Am J Cardiol; 1982 Jan; 49(1):45-55. PubMed ID: 7053610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bethanidine in hypertensive patients.
    Shen D; Gibaldi M; Israili A; Bellward G; Cunningham R; Throne M; Dayton P; McNay J
    Clin Pharmacol Ther; 1975 Mar; 17(3):363-73. PubMed ID: 1120401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of bethanidine, N-benzyl-N',N''-dimethylguanidine, in the rat, dog and man.
    Turnbull LB; Teng L; Newman J; Chremos AN; Bruce RB
    Drug Metab Dispos; 1976; 4(3):269-75. PubMed ID: 6232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of desipramine on the uptake and efflux of radiolabelled bretylium and bethanidine in the adventitial and media-intimal layers of rabbit aortic strips.
    Batmanglidj Eckhardt S; Maxwell RA; Copp FC
    Blood Vessels; 1977; 14(5):303-17. PubMed ID: 871533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of correlation between the oral pharmacokinetics and response to bethanidine [proceedings].
    Dring LG; Kamanyiro GH; Lancaster R; Smith RL
    Br J Clin Pharmacol; 1977 Jun; 4(3):390P-391P. PubMed ID: 901715
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of bethanidine in plasma by liquid-chromatography with a microbore reversed-phase column.
    Shipe JR; Arlinghaus AF; Savory J; Wills MR; DiMarco JP
    Clin Chem; 1983 Oct; 29(10):1793-5. PubMed ID: 6616825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent change in renal clearance of bethanidine in humans.
    Chremos AN; Shen D; Gibaldi M; Proctor JD; Newman JH
    J Pharm Sci; 1976 Jan; 65(1):140-2. PubMed ID: 1255421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of bethanidine sulfate on canine cardiac Purkinje fibers and ventricular muscle cells.
    Dangman KH; Miura DS
    J Cardiovasc Pharmacol; 1985; 7(1):50-8. PubMed ID: 2580150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
    Bacaner MB; Benditt DG
    Am J Cardiol; 1982 Oct; 50(4):728-34. PubMed ID: 6812406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bethanidine elimination from plasma.
    Corder CN
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):428-34. PubMed ID: 489762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bethanidine increased Na+ and Ca2+ currents and caused a positive inotropic effect in heart cells.
    Bkaily G; Payet MD; Benabderrazik M; Renaud JF; Sauvé R; Bacaner MB; Sperelakis N
    Can J Physiol Pharmacol; 1988 Mar; 66(3):190-6. PubMed ID: 3383015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
    Patterson E; Amalfitano DJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on bethanidine and meobentine: direct and indirect effects of antifibrillatory drugs.
    Dangman KH; Wang HH; Reynolds RD
    J Cardiovasc Pharmacol; 1986; 8(6):1185-94. PubMed ID: 2434745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model to describe myocardial drug disposition in the dog.
    Kates RE; Jaillon P
    J Pharmacol Exp Ther; 1980 Jul; 214(1):31-6. PubMed ID: 7391969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-catecholamine-mediated electrophysiological effects of intravenous bethanidine sulfate on the immature mammalian heart.
    Villafane J; Xu H; McCormack J; Gelband H; Stolfi A; Pickoff AS
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):486-91. PubMed ID: 2465451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE EFFECTS OF BETHANIDINE ON THE PERIPHERAL CIRCULATION IN MAN.
    FEWINGS JD; HODGE RL; SCROOP GC; WHELAN RF
    Br J Pharmacol Chemother; 1964 Aug; 23(1):115-22. PubMed ID: 14208188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bethanidine sulfate: efficacy in prevention of ventricular tachyarrhythmias during programmed stimulation. Report of a multicenter study of 56 patients.
    Teichman SL; Waspe LE; Matos JA; Kim SG; Fisher JD
    J Am Coll Cardiol; 1985 Sep; 6(3):510-7. PubMed ID: 3897340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bethanidine increases one type of potassium current and relaxes aortic muscle.
    Bkaily G; Caillé JP; Payet MD; Peyrow M; Sauvé R; Renaud JF; Sperelakis N
    Can J Physiol Pharmacol; 1988 Jun; 66(6):731-6. PubMed ID: 3167688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.